Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
32 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine from Gent, company number BE0460965081, closed financial year 2025 with a result of € 8,586 after tax. For that financial year Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine recorded a gross margin of € 9,067 and equity of € 222,941. Compared with financial year 2024, the result moved from € 2,222 to € 8,586. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.
€ 222,941
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 8,586
▲ 286% vs 2024
Profit after tax over the fiscal year.
€ 223,724
Cash and bank balances on the last day of the fiscal year.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,091
▲ € 3,145 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 1,318 | € 9,067 | ▲ € 7,748 |
| Profit after taxes | € 2,222 | € 8,586 | ▲ 286% |
| Equity | € 214,355 | € 222,941 | ▲ 4% |
| Total debts | € 26,017 | € 6,736 | ▼ 74% |
| Cash | € 223,091 | € 223,724 | |
| Retained profit | € 0 | € 8,586 | |
| Balance sheet total | € 240,372 | € 229,678 | ▼ 4% |
Key figures of Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine?
What happened at Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 8,586 (▲ 286% vs 2024). Source: NBB ↗
- Halil Yildiz became a director. NBB
- Steven Callens became a director. NBB
- Patrick Lacor became a director. NBB
- Frédéric-Alain Vandergheynst became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2,222 profit in 2024 to € 8,586 profit in 2025.
Best year ever: 2025, with € 8,586 profit.
A new publication or filing at Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine? We notify you, reason included.
Follow Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal MedicineDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine are Halil Yildiz, Steven Callens, Patrick Lacor and Frédéric-Alain Vandergheynst. Patrick Lacor is also behind Mana-Lacor.
Directors
According to the 2025 annual accounts
Halil Yildiz
Bestuurder - Zaakvoerder
since 2023
Steven Callens
Chairman of the board
since 2023
since 2023
Frédéric-Alain Vandergheynst
Bestuurder - Zaakvoerder
since 2023
Establishments
Establishment units
Physical locations of this company
Corneel Heymanslaan 10
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 32 companies are registered at this address.
All companies at this address →Universitair Ziekenhuis Gent
Samen Uit, Samen Thuis
Epilepsie Liga
VERENIGING VOOR VERPLEEGKUNDIGEN RADIOTHERAPIE EN ONCOLOGIE
Piekernie
+27 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0460.965.081
- VAT number
- BE 0460.965.081
- Registered office
- Corneel Heymanslaan 10, 9000 Gent
- Names & denominations
- Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine · B.V.I.G. - S.B.M.I. - B.S.M.I.
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 1 February 1997
- Peppol
- Active · Active since 1 Dec 2025
- Activities · NACE
Organisatie van congressen en beurzen